Abstract Details
|
Nicola De Stefano, MD
(University of Siena)
PRESENTER |
Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA. |
| Davorka Tomic | Davorka Tomic has stock in Meck KGaA. |
| Dieter Haering | Dieter Haering has received personal compensation for serving as an employee of Novartis. |
| No disclosure on file | |
| No disclosure on file | |
| Gordon S. Francis, MD, FAAN | No disclosure on file |
| Ernst-Wilhelm Radue, MD (Medical Image Analysis Center) | Dr. Radue has nothing to disclose. |
| Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) | Dr. Kappos has nothing to disclose. |